Skip to content
The Policy VaultThe Policy Vault

Lodoco (colchicine 0.5 mg tablets − Agepha)Cigna

Atherosclerotic Disease

Initial criteria

  • Patient age ≥ 18 years; AND
  • Patient has had one of the following conditions or diagnoses (i, ii, iii, iv, v, or vi): i. A previous myocardial infarction or a history of an acute coronary syndrome; OR ii. Angina (stable or unstable); OR iii. A past history of stroke or transient ischemic attack; OR iv. Coronary artery disease; OR v. Peripheral arterial disease; OR vi. Patient has undergone a coronary or other arterial revascularization procedure in the past; AND
  • Lodoco is being added onto other background regimens of atherosclerotic disease medications according to the prescriber; AND
  • Patient does not have severe hepatic impairment according to the prescriber; AND
  • Patient has a creatinine clearance ≥ 50 mL/min

Approval duration

1 year